Claim and evidence Close ×
The Framework states that the requirement that procurement for federally funded research be conducted through providers or manufacturers that adhere to the framework takes effect for all purchases of synthetic nucleic acids and benchtop nucleic acid synthesis equipment that take place on or after 26 April 2025. Copy claim link
Copy claim reference
Machine-checked, not reviewed by an editor Stated in source Supported
Supporting evidence: primary · 1 source
Provision Stated date · provision ID ostp-framework-funding-requirement-effective Subject version The copy served from the Biden White House archive, marked 'Revised: September 2024' with '2024 Version 1: April 2024' · Published 2024-04-29 · Effective date not established · Revised 2024-09 Date 2024-09 · revision Scope and limits States the date the framework sets for the requirement. Whether any funding agency established the requirement, and in what terms, is not recorded; the framework says agencies will do so under their own authorities, such as through award terms and conditions. The provision kind is `threshold`, the kind the dataset uses for a stated date of effect or application (`recorded separately`, `ny-effective-date`); the schema has no `date` kind. The record is dated by the expression that states the requirement, the revision of September 2024, because the schema dates a provision by one of its expression’s own dates. The day the framework states for application to purchases, 26 April 2025, is in the statement and in the quoted passage; it is not an effective date of any agency’s own terms and conditions. The provision kind is now `date` (schema 2.22), where part 1 used `threshold` on the dataset’s earlier precedent.
The evidence 02 primary source Supports the claim
Framework for Nucleic Acid Synthesis Screening (National Science and Technology Council, Fast Track Action Committee on Synthetic Nucleic Acid Procurement Screening) ↗ Office of Science and Technology Policy, Executive Office of the President (copy served from the Biden White House archive) · Publication date unknown
Copy source reference
Cite the original source Cite the original document, not Selekoa. Check these details against it.
Copy APA
Download BibTeX Download RIS Download CSL-JSON
Source excerpt “This requirement will take effect for all purchases of synthetic nucleic acids and benchtop nucleic synthesis equipment that take place on or after April 26, 2025.” Location in source II. Role of Federal Funding Agencies, p. 5
How it was read Retrieved directly from the publisher
Machine-checked · 2026-10-30
Source details and check notes Authors Office of Science and Technology Policy, Executive Office of the President (copy served from the Biden White House archive) Version Retrieved for the candidate pack on 2026-10-28 (SHA-256 3b083af856f92dfa91bbf5de344ca81761a4eb4c3a0323fa390e37330a802715). The copy linked from the HHS ASPR page on 2026-10-28, marked on its cover 'Revised: September 2024' with '2024 Version 1: April 2024'. The April 2024 version 1 was not retrieved. Technical passages (screening windows, matching methods, the criteria that may inform which sequences are in scope) were read but are not cited. Retrieved again at admission on 2026-10-30 (SHA-256 3b083af856f92dfa91bbf5de344ca81761a4eb4c3a0323fa390e37330a802715, the same bytes). Canonical address Open the canonical source ↗ Accessed 2026-10-28 Language English (en) Attribution Office of Science and Technology Policy, Executive Office of the President (copy served from the Biden White House archive), “Framework for Nucleic Acid Synthesis Screening (National Science and Technology Council, Fast Track Action Committee on Synthetic Nucleic Acid Procurement Screening)”. Reuse No open redistribution licence asserted. Bibliographic metadata, editorial paraphrases and short attributed quotations (at most 50 words each). Recheck terms before wider redistribution. Check notes Candidate pack passage, AI and biosecurity (research/ai-bio). The quotation (26 words) matched the text retrieved for the candidate pack on 2026-10-28 and again at admission on 2026-10-30, in a fresh retrieval whose SHA-256 equals the pack’s. Matching ignored differences of whitespace, case, quotation marks, dashes and Unicode compatibility forms, so the source’s typography can differ. Quoted as printed, including 'benchtop nucleic synthesis equipment'. A cross-family machine check (2026-10-30) re-read this record outside its brief, with the other records resting on the same source, and found the cited proposition supported. No human editorial review. primary source Supports the claim
Framework for Nucleic Acid Synthesis Screening (National Science and Technology Council, Fast Track Action Committee on Synthetic Nucleic Acid Procurement Screening) ↗ Office of Science and Technology Policy, Executive Office of the President (copy served from the Biden White House archive) · Publication date unknown
Copy source reference
Cite the original source Cite the original document, not Selekoa. Check these details against it.
Copy APA
Download BibTeX Download RIS Download CSL-JSON
Paraphrase the framework restates the Executive Order's requirement that all agencies funding life sciences research establish, as a requirement of funding and as appropriate and consistent with applicable law, that procurement for federally funded research is conducted through adhering providers or manufacturers.
Location in source II. Role of Federal Funding Agencies, p. 5
How it was read Retrieved directly from the publisher
Machine-checked · 2026-10-30
Source details and check notes Authors Office of Science and Technology Policy, Executive Office of the President (copy served from the Biden White House archive) Version Retrieved for the candidate pack on 2026-10-28 (SHA-256 3b083af856f92dfa91bbf5de344ca81761a4eb4c3a0323fa390e37330a802715). The copy linked from the HHS ASPR page on 2026-10-28, marked on its cover 'Revised: September 2024' with '2024 Version 1: April 2024'. The April 2024 version 1 was not retrieved. Technical passages (screening windows, matching methods, the criteria that may inform which sequences are in scope) were read but are not cited. Retrieved again at admission on 2026-10-30 (SHA-256 3b083af856f92dfa91bbf5de344ca81761a4eb4c3a0323fa390e37330a802715, the same bytes). Canonical address Open the canonical source ↗ Accessed 2026-10-28 Language English (en) Attribution Office of Science and Technology Policy, Executive Office of the President (copy served from the Biden White House archive), “Framework for Nucleic Acid Synthesis Screening (National Science and Technology Council, Fast Track Action Committee on Synthetic Nucleic Acid Procurement Screening)”. Reuse No open redistribution licence asserted. Bibliographic metadata, editorial paraphrases and short attributed quotations (at most 50 words each). Recheck terms before wider redistribution. Check notes Candidate pack passage, AI and biosecurity (research/ai-bio). The paraphrase is Selekoa’s, written from the text retrieved for the candidate pack on 2026-10-28; it is not a quotation and was not machine-matched. Explicit paraphrase; its footnote cites section 4.4(b)(iii) of the order and states that funding includes grants, contracts, cooperative agreements and other agreements. A cross-family machine check (2026-10-30) re-read this record outside its brief, with the other records resting on the same source, and found the cited proposition supported. No human editorial review. Status and meaning Editorial status. Not reviewed by an editor . An exploratory record that no editor has accepted. This status does not say whether a person has read any linked passage. Each evidence record above shows how it was checked.
Relation. An exact framework edition, or another document with an exact expression, states one provision: a capability threshold or risk level and its trigger, a required safeguard or action, a decision authority (who decides, recommends, can overrule or is informed), a stated exception, or another statement of its content, such as a licence term or a prospectus statement. The passage records what the document says, not implementation, compliance or effectiveness. Provisions with the same key align across editions of one family.
Date. Provision as the text states it, dated by its date of revision, September 2024. Release date 29 April 2024 from the HHS ASPR page, which also gives 'revised September 2024'; the cover of the retrieved copy carries 'Revised: September 2024' and '2024 Version 1: April 2024'. The day of the September 2024 revision is not stated and stays unknown. The framework's own effective date for the funding requirement, 26 April 2025, is recorded as a claim.
Record ID ab-scr-ostp-framework-funding-requirement-effective